Movchan Oleg

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Movchan Oleg's trades of Enfusion Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
456.57
Quantity 88,440 -7.4%
Value US$2,286,440
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
182.49
Quantity 34,899
Value US$4,266,006
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
250.55
Quantity 35,990 -25.0%
Value US$1,417,137
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
11.48
Quantity 2,790
Value US$32,033
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
10.13
Quantity 2,771 -0.5%
Value US$28,070
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
10.13
Quantity 2,771
Value US$28,072
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
8.95
Quantity 1,355 -0.5%
Value US$12,127
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
8.95
Quantity 1,355
Value US$12,127
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
9.23
Quantity 1,295 -0.5%
Value US$11,953
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
9.23
Quantity 1,295
Value US$11,956
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
10.01
Quantity 100,000 -8.0%
Value US$1,001,000
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
10.09
Quantity 150,000 -10.7%
Value US$1,513,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-07 2025-03-06
US Enfusion Inc (ENFN)
S Sale
88,440 -7.4%
456.57
US$2,286,440 		88,440 -7.4% 456.57 US$2,286,440
2025-03-06 2025-03-06
US Enfusion Inc (ENFN)
PrS Proposed sale
34,899
182.49
US$4,266,006 		34,899 182.49 US$4,266,006
2025-03-05 2025-03-03
US Enfusion Inc (ENFN)
S Sale
35,990 -25.0%
250.55
US$1,417,137 		35,990 -25.0% 250.55 US$1,417,137
2025-03-03 2025-03-03
US Enfusion Inc (ENFN)
PrS Proposed sale
2,790
11.48
US$32,033 		2,790 11.48 US$32,033
2025-01-10 2025-01-07
US Enfusion Inc (ENFN)
S Sale
2,771 -0.5%
10.13
US$28,070 		2,771 -0.5% 10.13 US$28,070
2025-01-07 2025-01-07
US Enfusion Inc (ENFN)
PrS Proposed sale
2,771
10.13
US$28,072 		2,771 10.13 US$28,072
2024-01-10 2024-01-09
US Enfusion Inc (ENFN)
S Sale
1,355 -0.5%
8.95
US$12,127 		1,355 -0.5% 8.95 US$12,127
2024-01-09 2024-01-09
US Enfusion Inc (ENFN)
PrS Proposed sale
1,355
8.95
US$12,127 		1,355 8.95 US$12,127
2024-01-10 2024-01-08
US Enfusion Inc (ENFN)
S Sale
1,295 -0.5%
9.23
US$11,953 		1,295 -0.5% 9.23 US$11,953
2024-01-08 2024-01-08
US Enfusion Inc (ENFN)
PrS Proposed sale
1,295
9.23
US$11,956 		1,295 9.23 US$11,956
2023-12-18 2023-12-14
US Enfusion Inc (ENFN)
S Sale
100,000 -8.0%
10.01
US$1,001,000 		100,000 -8.0% 10.01 US$1,001,000
2023-12-05 2023-12-01
US Enfusion Inc (ENFN)
S Sale
150,000 -10.7%
10.09
US$1,513,500 		150,000 -10.7% 10.09 US$1,513,500